UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1424) 1424
angioedema - chemically induced (1299) 1299
science & technology (863) 863
life sciences & biomedicine (857) 857
female (815) 815
male (694) 694
middle aged (568) 568
angiotensin-converting enzyme inhibitors - adverse effects (549) 549
adult (476) 476
aged (403) 403
angioedema (301) 301
urticaria - chemically induced (262) 262
allergy (218) 218
angioedema - diagnosis (206) 206
abridged index medicus (201) 201
immunology (191) 191
general & internal medicine (183) 183
angioedema - drug therapy (169) 169
angioneurotic edema (166) 166
medicine, general & internal (166) 166
drug hypersensitivity - etiology (155) 155
hypertension - drug therapy (143) 143
adolescent (134) 134
anti-inflammatory agents, non-steroidal - adverse effects (130) 130
angiotensin-converting enzyme inhibitors - therapeutic use (128) 128
risk factors (126) 126
ace inhibitors (111) 111
enalapril - adverse effects (110) 110
pharmacology & pharmacy (108) 108
aged, 80 and over (103) 103
angioedema - therapy (103) 103
anaphylaxis - chemically induced (100) 100
drug hypersensitivity - diagnosis (97) 97
aspirin - adverse effects (94) 94
antihypertensive agents - adverse effects (92) 92
dermatology (87) 87
retrospective studies (87) 87
time factors (86) 86
urticaria (85) 85
diagnosis, differential (83) 83
enzymes (78) 78
drug eruptions - etiology (77) 77
angioedema - epidemiology (76) 76
treatment outcome (76) 76
angioedema - immunology (75) 75
tongue diseases - chemically induced (72) 72
child (71) 71
lisinopril - adverse effects (71) 71
angioedema - physiopathology (68) 68
skin tests (66) 66
angioedema - genetics (61) 61
angiotensin (61) 61
drug therapy (61) 61
angioedema - complications (59) 59
angioedema - pathology (59) 59
child, preschool (56) 56
cardiovascular system & cardiology (55) 55
angiotensin-converting enzyme inhibitors (52) 52
bradykinin (51) 51
tissue plasminogen activator - adverse effects (51) 51
asthma - chemically induced (49) 49
complications and side effects (49) 49
drug hypersensitivity - immunology (48) 48
hypertension (48) 48
angioedema - diagnostic imaging (47) 47
young adult (47) 47
angiotensin-converting enzyme inhibitors - administration & dosage (46) 46
internal medicine (46) 46
animals (45) 45
emergency medicine (45) 45
captopril - adverse effects (44) 44
care and treatment (44) 44
tomography, x-ray computed (44) 44
incidence (43) 43
urticaria - immunology (43) 43
allergy and immunology (42) 42
angioedema - etiology (42) 42
bradykinin - analogs & derivatives (42) 42
edema (41) 41
aspirin (39) 39
dentistry (39) 39
fibrinolytic agents - adverse effects (39) 39
patients (39) 39
hypersensitivity (38) 38
stroke - drug therapy (38) 38
angiotensin receptor antagonists (37) 37
drugs (37) 37
follow-up studies (37) 37
heart failure - drug therapy (37) 37
neurosciences & neurology (37) 37
administration, oral (36) 36
antihypertensive agents - therapeutic use (36) 36
mouth diseases - chemically induced (36) 36
recurrence (36) 36
urticaria - diagnosis (36) 36
angiotensin-converting enzyme inhibitor (35) 35
anti-bacterial agents - adverse effects (35) 35
chronic disease (35) 35
cough - chemically induced (35) 35
medicine & public health (35) 35
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1228) 1228
German (68) 68
French (63) 63
Spanish (36) 36
Italian (15) 15
Japanese (14) 14
Dutch (12) 12
Russian (9) 9
Danish (7) 7
Polish (6) 6
Swedish (6) 6
Hungarian (4) 4
Finnish (3) 3
Norwegian (3) 3
Portuguese (3) 3
Serbian (2) 2
Chinese (1) 1
Czech (1) 1
Hebrew (1) 1
Lithuanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Drug safety, ISSN 0114-5916, 2008, Volume 31, Issue 11, pp. 1017 - 1026
Background: Bupropion was the first alternative to nicotine replacement therapy in the pharmacological treatment for smoking cessation. Its safety profile has... 
Bupropion, adverse reactions | Smoking cessation therapies, adverse reactions | Pharmacology & Pharmacy | Public, Environmental & Occupational Health | Toxicology | Life Sciences & Biomedicine | Science & Technology | Antidepressive Agents, Second-Generation - adverse effects | Death, Sudden, Cardiac - epidemiology | Humans | Middle Aged | Suicide, Attempted - statistics & numerical data | Male | Antidepressive Agents, Second-Generation - therapeutic use | Seizures - chemically induced | Serum Sickness - chemically induced | Young Adult | Nervous System Diseases - epidemiology | Drug Overdose - epidemiology | Product Surveillance, Postmarketing | Adult | Female | Cerebrovascular Disorders - epidemiology | Serum Sickness - epidemiology | Bupropion - adverse effects | Bupropion - therapeutic use | Databases, Factual | Myocardial Ischemia - epidemiology | Cerebrovascular Disorders - chemically induced | France - epidemiology | Angioedema - epidemiology | Mental Disorders - epidemiology | Myocardial Ischemia - chemically induced | Mental Disorders - chemically induced | Risk Factors | Suicide - statistics & numerical data | Mental Disorders - psychology | Seizures - epidemiology | Adolescent | Angioedema - chemically induced | Nervous System Diseases - chemically induced | Aged | Drug Eruptions - epidemiology | Smoking Cessation | Index Medicus
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2008, Volume 372, Issue 9644, pp. 1174 - 1183
Journal Article
Allergy (Copenhagen), ISSN 1398-9995, 10/2007, Volume 62, Issue 10, pp. 1111 - 1118
Journal Article
The New England journal of medicine, ISSN 1533-4406, 10/2019, Volume 381, Issue 17, pp. 1609 - 1620
Patients with heart failure with preserved ejection fraction were assigned to receive sacubitril–valsartan or valsartan. At a median of 35 months, there was no... 
MIDDLE CHILD | MIDRANGE | IMPAIRED SYSTOLIC FUNCTION | SPIRONOLACTONE | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Single-Blind Method | Valsartan - administration & dosage | Follow-Up Studies | Humans | Middle Aged | Heart Failure - physiopathology | Aminobutyrates - adverse effects | Hospitalization - statistics & numerical data | Male | Tetrazoles - administration & dosage | Cardiovascular Diseases - mortality | Female | Aminobutyrates - administration & dosage | Double-Blind Method | Valsartan - adverse effects | Hypotension - chemically induced | Heart Failure - drug therapy | Stroke Volume | Neprilysin - antagonists & inhibitors | Sex Factors | Quality of Life | Angioedema - chemically induced | Aged | Tetrazoles - adverse effects | Angiotensin Receptor Antagonists - administration & dosage | Angiotensin Receptor Antagonists - adverse effects | Heart failure | Treatment outcome | Care and treatment | Usage | Safety and security measures | Hospitals | Patient outcomes | Analysis | Angiotensin | Causes of | Statistics | Admission and discharge | Renal function | Cardiomyopathy | Mortality | Angioedema | Clinical trials | Hospitalization | Coronary artery disease | Hypotension | Heart rate | Hyperkalemia | Patient safety | Death | Neprilysin | Heart diseases | Pharmaceuticals | Ejection fraction | Index Medicus | Abridged Index Medicus
Journal Article
The Medical clinics of North America, ISSN 0025-7125, 07/2010, Volume 94, Issue 4, pp. 711 - 725
Journal Article
The New England journal of medicine, ISSN 1533-4406, 01/2015, Volume 372, Issue 5, pp. 418 - 425
Journal Article